Lung Adenocarcinoma Articles & Analysis
5 articles found
Lung cancer is a major type of cancer in the world, with the highest morbidity and mortality among all malignant tumors. ...
Abstract Lung cancer mortality remains high even after successful resection. Adjuvant treatment benefits stage II and III patients, but not stage I patients, and most studies fail to predict recurrence in stage I patients. Our study included 211 lung adenocarcinoma patients (stages I–IIIA; 81% stage I) who received curative resections at ...
Abstract Background: Five-year survival for stage I-II lung cancer is quite low even after complete surgical resection. Current guidelines recommend adjuvant treatment only for selected patients with stage II or higher disease. ...
Subsequently, the researchers developed CAR-T cells with specificity for OR2H1 protein. OR2H1 CAR-T cells can kill lung cancer and ovarian cancer cells expressing OR2H1, but have no effect on healthy cells. In addition, OR2H1 CAR-T cells also have certain anti-tumor effect in immunodeficient mice challenged with human tumors. In lung cancer and ovarian cancer ...
NEW YORK - Spanish cancer research firm Universal Diagnostics is gearing up to commercialize a liquid biopsy test that applies methylation biomarkers to detect lung cancer, based on data presented at the International Association for the Study of Lung Cancer 2020 World Conference for Lung Cancer (WCLC) last month. ...